Enteropathogen Changes After Rotavirus Vaccine Scale-up
Open Access
- 23 December 2021
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 149 (1)
Abstract
To inform next steps in pediatric diarrhea burden reduction by understanding the shifting enteropathogen landscape after rotavirus vaccine implementation. We conducted a case-control study of 1788 medically attended children younger than 5 years, with and without gastroenteritis, after universal rotavirus vaccine implementation in Peru. We tested case and control stools for 5 viruses, 19 bacteria, and parasites; calculated coinfection-adjusted attributable fractions (AFs) to determine pathogen-specific burdens; and evaluated pathogen-specific gastroenteritis severity using Clark and Vesikari scales. Six pathogens were independently positively associated with gastroenteritis: norovirus genogroup II (GII) (AF 29.1, 95% confidence interval [CI]: 28.0–32.3), rotavirus (AF 8.9, 95% CI: 6.8–9.7), sapovirus (AF 6.3, 95% CI: 4.3–7.4), astrovirus (AF 2.8, 95% CI: 0.0–4.0); enterotoxigenic Escherichia coli heat stable and/or heat labile and heat stable (AF 2.4, 95% CI: 0.6–3.1), and Shigella spp. (AF 2.0, 95% CI: 0.4–2.2). Among typeable rotavirus cases, we most frequently identified partially heterotypic strain G12P[8] (54 of 81, 67%). Mean severity was significantly higher for norovirus GII–positive cases relative to norovirus GII–negative cases (Vesikari [12.7 vs 11.8; P < .001] and Clark [11.7 vs 11.4; P = .016]), and cases in the 6- to 12-month age range relative to cases in other age groups (Vesikari [12.7 vs 12.0; P = .0002] and Clark [12.0 vs 11.4; P = .0016]). Norovirus is well recognized as the leading cause of pediatric gastroenteritis in settings with universal rotavirus vaccination. However, sapovirus is often overlooked. Both norovirus and sapovirus contribute significantly to the severe pediatric disease burden in this setting. Decision-makers should consider multivalent vaccine acquisition strategies to target multiple caliciviruses in similar countries after successful rotavirus vaccine implementation.Keywords
This publication has 47 references indexed in Scilit:
- Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trialBMC Infectious Diseases, 2012
- Identification of lineage III of G12 rotavirus strains in diarrheic children in the Northern Region of Brazil between 2008 and 2010Archives of Virology, 2011
- An automated genotyping tool for enteroviruses and norovirusesJournal of Clinical Virology, 2011
- Rotavirus genotypes in children in the Basque Country (northern Spain) over a 13-year period (July 1996–June 2009)European Journal of Clinical Microbiology & Infectious Diseases, 2010
- Characterization of genotype P[9]G12 rotavirus strains from argentina: High similarity with Japanese and Korean G12 strainsJournal of Medical Virology, 2008
- Enhancement of detection and quantification of rotavirus in stool using a modified real‐time RT‐PCR assayJournal of Medical Virology, 2008
- Prevalence of sapovirus infection among infants and children with acute gastroenteritis in Dhaka City, Bangladesh during 2004–2005Journal of Medical Virology, 2007
- Evolutionary History and Global Spread of the Emerging G12 Human RotavirusesJournal of Virology, 2007
- Rotavirus diarrhea in children and adults in a southern city of Brazil in 2003: Distribution of G/P types and finding of a rare G12 strainJournal of Medical Virology, 2006
- Enteropathogens and Other Factors Associated with Severe Disease in Children with Acute Watery Diarrhea in Lima, PeruThe Journal of Infectious Diseases, 1999